Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient has been tested with the Trial Tool (DTO) and demonstrated the potential to utilize the C-Brace successfully~* Patient has a BBS score \< 45~* Lower limb functional impairment according to CE label wording~* Prior active and compliant use of unilateral or bilateral KAFO or SCO in the past 3 months prior to enrollment in the study~* Patient meets minimum physical requirements to be fitted with a C-Brace, such as muscle status, joint mobility, leg axis and proper control of the orthosis must be guaranteed.~* The User must fulfill the physical and mental requirements for perceiving optical/acoustic signals and/or mechanical vibrations~* The existing muscle strength of the hip extensors and flexors must permit the controlled swing-through of the limb (compensation using the hip is possible).~* Patient´s commitment to use C-Brace 2 at least 1-2 hours per day 5 days per week-~* Patient is ≥ 18 years old~* Patient is willing and able to independently provide informed consent.~* Person is willing to comply with study procedures~Exclusion Criteria:~* Patient who is not able to follow the entire study visits or is unwilling/unable to follow the instructions~* Patient was not able to use DTO~* Patient who is not using an orthosis at least 1 to 2 hours/ day for 5 days per week~* Patient with body weight \> 125 kg (includes body weight and heaviest object (weight) carried)~* Patient with Orthoprosthesis~* Patient with flexion contracture in the knee and/or hip joint in excess of 10°~* Patient with uncontrolled moderate to severe spasticity (relative contraindication moderate spasticity)~* Leg length discrepancy in excess of 15 cm~* Patient with unstable neurological or cardiovascular/pulmonary disease, cancer~* Pregnancy~* Patient using a C-Brace~* Patient with known vertigo or with history of falls unrelated to orthosis use or unrelated to motor disability~* Patient who has never been fitted an orthosis before~* Patient is not able to answer the self-administered questionnaires independently; for patients with upper extremity impairment is it allowed to verbally answer the questions.~* Patient participating already in a study during this study´s duration~* Patient participated in earlier C-Brace studies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- KAFO/SCO (Type: ACTIVE_COMPARATOR): Home use of 3 months with existing knee ankle foot orthosis (KAFO) or existing stance control orthosis (SCO)
- C-Brace (Type: EXPERIMENTAL): Home use of 3 months with newly fitted C-Brace microprocessor-controlled stance and swing control orthosis.

Based on this trial design, predict the completion outcome and termination type (if applicable).